Literature DB >> 31169577

Saline Solution Lavage and Reaspiration for Culture with a Blood Culture System Is a Feasible Method for Diagnosing Periprosthetic Joint Infection in Patients with Insufficient Synovial Fluid.

Rui Li1, Qiang Lu1, Wei Chai1, Li-Bo Hao1, Shi-Bi Lu1, Ji-Ying Chen1.   

Abstract

BACKGROUND: Culture is a key step for detecting periprosthetic joint infection (PJI) before surgery. However, using saline solution lavage and reaspiration in patients with insufficient synovial fluid remains controversial. The objective of this study was to evaluate this technique.
METHODS: This study included 286 aspirations performed by 1 surgeon in patients after total joint arthroplasty during the period of April 2015 to August 2018. If >1.0 mL of synovial fluid was obtained, then we directly used the fluid for culture. For cases in which ≤1.0 mL of synovial fluid was aspirated, 10 mL of saline solution was injected and the joint was reaspirated for culture. The samples were injected into 2 blood culture bottles for anaerobic bacterial culture and aerobic bacterial and fungal culture, and were inoculated for 14 days in a BACT/ALERT 3D blood culture system unless microorganisms were detected. A PJI diagnosis was determined on the basis of the modified Musculoskeletal Infection Society criteria.
RESULTS: Saline solution lavage and reaspiration were used in 82 cases (47 PJI cases and 35 non-PJI cases), while direct aspiration was used in 204 cases (99 PJI cases and 105 non-PJI cases). The overall rate for the use of saline solution lavage was 28.7% (82 of 286). Among knee cases, the saline solution lavage rate was 15.0% (21 of 140), and among hip cases, the rate was 41.8% (61 of 146). The overall sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of culture were 0.795 (95% confidence interval [CI], 0.720 to 0.857), 0.957 (95% CI, 0.909 to 0.984), 0.951 (95% CI, 0.896 to 0.982), and 0.817 (95% CI, 0.749 to 0.873); and for "dry tap" cases, they were 0.851 (95% CI, 0.717 to 0.938), 0.857 (95% CI, 0.697 to 0.952), 0.889 (95% CI, 0.760 to 0.963), and 0.811 (95% CI, 0.648 to 0.920), respectively.
CONCLUSIONS: Saline solution lavage and reaspiration for culture in patients with insufficient synovial fluid before surgery may be a sound practice. LEVEL OF EVIDENCE: Diagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31169577     DOI: 10.2106/JBJS.18.01052

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  6 in total

1.  Diagnostic value of fluoroscopy-guided hip aspiration for periprosthetic joint infection.

Authors:  Thanat Kanthawang; Jannis Bodden; Gabby B Joseph; Thomas Vail; Derek Ward; Rina Patel; Thomas M Link
Journal:  Skeletal Radiol       Date:  2021-05-06       Impact factor: 2.199

2.  Saline lavage and reaspiration for the diagnosis of periprosthetic joint infections.

Authors:  Hytham S Salem; Joseph O Ehiorobo; Kevin K Mathew; Michael A Mont
Journal:  Ann Transl Med       Date:  2019-12

3.  What's New in Musculoskeletal Infection.

Authors:  Thomas K Fehring; Keith A Fehring; Angela Hewlett; Carlos A Higuera; Jesse E Otero; Aaron J Tande
Journal:  J Bone Joint Surg Am       Date:  2020-07-15       Impact factor: 6.558

4.  Indications and Future Perspectives of a Minimally Invasive Ultrasound-guided Double-needle Joint Lavage.

Authors:  Rajendra Kumar Sahoo; Felice Galluccio; Ke-Vin Chang; Mario Fajardo Perez
Journal:  J Med Ultrasound       Date:  2021-05-14

5.  Synovial Fluid Aspirates Diluted with Saline or Blood Reduce the Sensitivity of Traditional and Contemporary Synovial Fluid Biomarkers.

Authors:  Carl Deirmengian; Scott Feeley; Gregory S Kazarian; Keith Kardos
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

6.  Factors predicting hip joint aspiration yield or "dry taps" in patients with total hip arthroplasty.

Authors:  Justin Ong; Alex Tang; Joshua C Rozell; James S Babb; Ran Schwarzkopf; Dana Lin
Journal:  J Orthop Surg Res       Date:  2022-01-22       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.